Tarsus Pharmaceuticals, Inc. /
Alkeus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. completed its deal for Alkeus Pharmaceuticals, Inc.
Source for the buyer and target: Tarsus Pharmaceuticals, Inc.
For the buyer and target.
“On September 4, 2026 (the “Closing Date”), Tarsus Pharmaceuticals, Inc. (the “Company”) completed its previously announced acquisition of Alkeus Pharmaceuticals, Inc., a Delaware corporation (“Alkeus”), pursuant to that certain Agreement and Plan of Merger, dated as of July 31, 2026 (the “Merger Agreement”), by and among the Company, Alkeus, Apex 2026 Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of the Company (“Merger Sub”), and Shareholder Representative Services LLC, a Colorado limited liability company solely in its capacity as the securityholders’ representative.”
Published 10 Sep 2026
Open the sourceWhat happened
The deal for Alkeus Pharmaceuticals, Inc. has closed, with Tarsus Pharmaceuticals, Inc. as the buyer, at a stated price of $270,000,000. [01]
The filing from Tarsus Pharmaceuticals, Inc. is dated Sept. 10, 2026. [01]
The source
Everything on this page comes from the source below, quoted word for word.
Tarsus Pharmaceuticals, Inc. completed its deal for Alkeus Pharmaceuticals, Inc.
This document is the source for the companies, stage and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly